The Technical Analyst
RxSight, Inc. [RXST]
Exchange: NASDAQ Global Market Sector: Healthcare Industry: Medical Devices
RxSight, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.04% $26.22
America/New_York / 6 jun 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 891.01 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | May 09, 2023 |
| SharesOutstanding: | 33.98 mill |
| Avg Daily Volume: | 0.307 mill |
| RATING 2023-06-06 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.05x |
| Company: PE 0 | industry: PE 229.20 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$26.65 (1.63%) $0.428 |
| Date: 2023-06-07 |
| Expected Trading Range (DAY) |
|---|
|
$ 25.10 - 27.34 ( +/- 4.26%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-06-01 | Warner Robert Keith | Buy | 5 731 | Common Stock |
| 2023-06-01 | Tammenoms Bakker Juliet | Buy | 5 731 | Common Stock |
| 2023-06-01 | Palmisano Robert J | Buy | 5 731 | Common Stock |
| 2023-06-01 | Maniar Shweta | Buy | 5 731 | Common Stock |
| 2023-06-01 | Link William J Phd | Buy | 5 731 | Common Stock |
| INSIDER POWER |
|---|
| 8.73 |
| Last 93 transactions |
| Buy: 12 425 595 | Sell: 9 868 041 |
Forecast:
16:00 - $26.22
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $26.22
Forecast 2: 16:00 - $26.22
Forecast 3: 16:00 - $26.22
SCORE
-10.00
Sell
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $26.22 (0.04% ) |
| Volume | 0.579 mill |
| Avg. Vol. | 0.307 mill |
| % of Avg. Vol | 188.83 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For RXST
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
RXST
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Last 10 Buy Signals
Latest Press Releases
2023-04-24 16:05:00 - Press Release
Multiple Surgeon Presentations To Highlight Rxsight® Light Adjustable Lens System At Upcoming American Society Of Cataract And Refractive Surgery Annual Meeting
Aliso viejo, calif., april 24, 2023 (globe newswire) -- (nasdaq: rxst) – rxsight, inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that its light adjustable lens™ system will be the subject of multiple surgeon presentations at the annual meeting of the american society of cataract and refractive surgery (ascrs) being held at the san diego convention center on may 5-8, 2023.
2023-03-06 16:05:00 - Press Release
Rxsight, Inc. Reports Fourth Quarter And Full Year 2022 Financial Results
Aliso viejo, calif., march 06, 2023 (globe newswire) -- (nasdaq: rxst) – rxsight, inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months and full year ended december 31, 2022.
2023-02-14 16:05:00 - Press Release
Rxsight, Inc. Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares And Closing Of Its Public Offering Of Common Stock
Aliso viejo, calif., feb. 14, 2023 (globe newswire) -- rxsight, inc. (“rxsight®”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that, in connection with its previously announced public offering of common stock (the “offering”), the underwriters exercised in full their option to purchase an additional 600,000 shares of rxsight's common stock at a public offering price of $12.50 per share.
2023-02-08 00:45:00 - Press Release
Rxsight, Inc. Announces Pricing Of Public Offering Of Common Stock
Aliso viejo, calif., feb. 07, 2023 (globe newswire) -- (nasdaq: rxst) – rxsight, inc. (“rxsight”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, announced today that it has priced its underwritten public offering. rxsight expects to sell 4,000,000 shares of its common stock at a price to the public of $12.50 per share. rxsight has granted the underwriter a 30-day option to purchase up to an additional 600,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. all of the shares are to be sold by rxsight. before deducting the underwriting discount and estimated offering expenses payable by rxsight, rxsight expects to receive gross proceeds of approximately $50...
2023-01-08 16:00:00 - Press Release
Rxsight, Inc. Announces Preliminary Unaudited Fourth Quarter And Full Year 2022 Financial And Operational Results
Aliso viejo, calif., jan. 08, 2023 (globe newswire) -- (nasdaq: rxst) – rxsight, inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2022.
Latest News
2023-05-13 19:14:09 - Seeking Alpha
RxSight, Inc. (RXST) Q1 2023 Earnings Call Transcript
RxSight, Inc. (NASDAQ:RXST ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Alex Huang - Director, IR Ron Kurtz - President and CEO Shelley Thunen - CFO Conference Call Participants Allen Gong - JP Morgan Craig Bijou - Bank of America Joseph Conway - Needham & Co. Ryan Zimmerman - BTIG Steven Lichtman - Oppenheimer Lawrence Biegelsen - Wells Fargo Operator Welcome to the RxSight First Quarter 2023 Earnings Conference Call. Please be advised that today's conference is being recorded.
2023-05-09 19:52:45 - Zacks Investment Research
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates
RxSight, Inc. (RXST) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.54 per share a year ago.
2023-04-26 16:05:00 - GlobeNewsWire
RxSight, Inc. to Present at the Bank of America Healthcare Conference
ALISO VIEJO, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference.
2023-04-25 16:05:00 - GlobeNewsWire
RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023
ALISO VIEJO, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the first quarter 2023 after the market close on Tuesday, May 9, 2023. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
2023-04-11 13:02:21 - Zacks Investment Research
Here's Why RxSight, Inc. (RXST) is a Great Momentum Stock to Buy
Does RxSight, Inc. (RXST) have what it takes to be a top stock pick for momentum investors? Let's find out.
2023-04-05 16:05:00 - GlobeNewsWire
RxSight, Inc. to Present at the Needham Healthcare Conference
ALISO VIEJO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Needham Healthcare Conference.
2023-03-29 09:13:27 - Zacks Investment Research
4 Best Breakout Stocks to Buy Now for Superlative Returns
CymaBay Therapeutics (CBAY), RxSight (RXST), UWM (UWMC) & Remitly Global (RELY) have been selected as the breakout stocks for today.
2023-03-13 11:29:31 - Zacks Investment Research
How Much Upside is Left in RxSight, Inc. (RXST)? Wall Street Analysts Think 25.69%
The consensus price target hints at a 25.7% upside potential for RxSight, Inc. (RXST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
2023-03-06 20:19:10 - Seeking Alpha
RxSight, Inc. (RXST) Q4 2022 Earnings Call Transcript
RxSight, Inc. (NASDAQ:RXST ) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ET Company Participants Alex Huang – Investor Relations Ron Kurtz – President and Chief Executive Officer Shelley Thunen – Chief Financial Officer Conference Call Participants Craig Bijou – Bank of America Robbie Marcus – JPMorgan Ryan Zimmerman – BTIG David Saxon – Needham Operator Good day and thank you for standing by. Welcome to the RxSight Fourth Quarter Earnings Conference Call.
2023-02-28 16:05:00 - GlobeNewsWire
RxSight, Inc. to Present at the Oppenheimer Healthcare Conference
ALISO VIEJO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Oppenheimer Healthcare Conference.